Profile data is unavailable for this security.
About the company
Getein Biotech Inc is a China-based company principally engaged in the research, development, production, sales, and service of in vitro diagnostic (IVD) reagents and instruments. The Company's main reagent products include point-of-care testing (POCT) reagents, chemiluminescence reagents, biochemical reagents, and hematology reagents. The Company's main instrument products include the FIA 8000 Quantitative lmmunoassay Analyzer, Getein 1100 Immunofluorescence Quantitative Analyzer, CM-400 Clinical Chemistry Analyzer, MAGICL 6000 Chemiluminescence Immunoassay Analyzer, Metis 6000 Modular System, BHA-3000 Automatic Hematology Analyzer and CA-5500 Automated Coagulation Analyzer. The Company mainly operates its businesses in the domestic market and overseas markets.
- Revenue in CNY (TTM)1.04bn
- Net income in CNY181.90m
- Incorporated2002
- Employees1.95k
- LocationGetein Biotech IncNo. 9, Bofu Road, Yanjiang IndustrialDevelopment Zone, Liuhe DistrictNANJING 211505ChinaCHN
- Phone+86 2 568568577
- Fax+86 2 568568577
- Websitehttps://www.getein.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Gongdong Medical Techno Co Ltd | 1.12bn | 102.20m | 4.34bn | 1.69k | 42.21 | 2.53 | -- | 3.86 | 0.466 | 0.466 | 5.13 | 7.78 | 0.5465 | 6.12 | 3.84 | 664,064.40 | 4.96 | 14.20 | 5.91 | 16.37 | 29.10 | 39.16 | 9.07 | 20.48 | 2.65 | -- | 0.0978 | 42.51 | 14.37 | 15.06 | 57.28 | 8.61 | 1.39 | -- |
| Well Lead Medical Co Ltd | 1.64bn | 244.31m | 4.37bn | 2.76k | 18.07 | 2.26 | -- | 2.67 | 0.8288 | 0.8288 | 5.57 | 6.63 | 0.5811 | 4.75 | 6.81 | 593,586.30 | 9.07 | 8.23 | 11.07 | 10.15 | 42.85 | 43.50 | 15.61 | 13.60 | 1.39 | 82.37 | 0.2436 | 57.82 | 8.76 | 8.72 | 13.98 | 12.61 | 22.91 | 26.58 |
| Jianerkang Medical Co Ltd | 988.21m | 103.17m | 4.44bn | 1.64k | 17.85 | 3.04 | -- | 4.49 | 1.59 | 1.59 | 8.03 | 9.35 | 0.6961 | 4.54 | 4.50 | 603,301.80 | 7.27 | -- | 8.08 | -- | 23.15 | -- | 10.44 | -- | 7.07 | -- | 0.0146 | -- | 1.18 | -- | -2.69 | -- | -- | -- |
| Nanjing Medlander Medical Tech Co Ltd | 437.82m | 101.51m | 4.46bn | 582.00 | 42.98 | 3.26 | -- | 10.19 | 1.04 | 1.04 | 4.47 | 13.68 | 0.2865 | 2.18 | 15.40 | 752,267.60 | 6.81 | 11.96 | 7.54 | 13.89 | 69.16 | 71.98 | 23.76 | 31.41 | 8.22 | -- | 0.0268 | 48.42 | 24.57 | 10.68 | 13.10 | -0.8601 | 23.21 | -- |
| Getein Biotech Inc | 1.04bn | 181.90m | 4.51bn | 1.95k | 24.79 | 1.68 | -- | 4.32 | 0.3587 | 0.3587 | 2.06 | 5.31 | 0.2683 | 1.68 | 2.68 | 535,523.10 | 4.41 | 10.90 | 6.31 | 15.53 | 67.54 | 64.96 | 16.43 | 25.58 | 2.14 | -- | 0.1839 | 31.15 | -14.93 | 3.77 | -20.06 | -8.02 | 4.62 | -2.48 |
| Thalys Medical Technology Group Corp | 1.25bn | -240.46m | 4.67bn | 1.25k | -- | 4.28 | -- | 3.74 | -1.35 | -1.35 | 6.55 | 5.19 | 0.4777 | 3.80 | 1.12 | 1,001,425.00 | -9.15 | -2.70 | -16.94 | -4.93 | 18.26 | 20.43 | -19.16 | -4.59 | 1.16 | -2.08 | 0.357 | -- | -9.74 | -0.2204 | -31.95 | -- | -24.80 | -- |
| Chimin Health Management Co Ltd | 637.78m | -165.28m | 4.72bn | 1.99k | -- | 3.36 | -- | 7.39 | -0.3276 | -0.3276 | 1.24 | 2.67 | 0.2591 | 3.15 | 3.72 | 319,848.50 | -6.70 | 0.4271 | -9.09 | 0.6335 | 27.94 | 42.63 | -25.86 | 1.16 | 0.8238 | -8.24 | 0.3308 | 65.53 | -13.28 | 0.1151 | 8.81 | -- | -1.88 | -- |
| CareRay Digital Medical Technology CoLtd | 328.62m | 5.41m | 4.74bn | 282.00 | 825.27 | 5.52 | -- | 14.41 | 0.0651 | 0.0651 | 3.79 | 9.74 | 0.3392 | 1.69 | 3.66 | 1,165,314.00 | 0.5362 | 4.81 | 0.5972 | 5.27 | 36.13 | 40.00 | 1.58 | 12.87 | 3.57 | 1.77 | 0.0497 | 34.94 | 8.90 | 4.91 | 14.54 | -18.19 | 85.59 | -- |
| Innovita Biological Technology Co Ltd | 430.96m | 133.44m | 4.81bn | 547.00 | 35.94 | 2.37 | -- | 11.17 | 0.9778 | 0.9778 | 3.15 | 14.84 | 0.1992 | 2.28 | 12.73 | 787,869.50 | 6.17 | 18.66 | 6.52 | 20.97 | 76.43 | 78.34 | 30.96 | 43.42 | 16.16 | -- | 0.0025 | 12.05 | 29.99 | 35.11 | 41.92 | 63.25 | 28.63 | -- |
Data as of Feb 11 2026. Currency figures normalised to Getein Biotech Inc's reporting currency: Chinese Yuan Renminbi CNY
0.70%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025 | 824.47k | 0.16% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 719.43k | 0.14% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2025 | 480.67k | 0.10% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 445.51k | 0.09% |
| Acadian Asset Management LLCas of 30 Sep 2025 | 409.96k | 0.08% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 290.09k | 0.06% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 171.78k | 0.03% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 88.58k | 0.02% |
| Great Wall Fund Management Co., Ltd.as of 30 Jun 2025 | 59.30k | 0.01% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 59.02k | 0.01% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
